文献速递痛风与晶体性关节病

急性焦磷酸钙晶体关节炎患者与匹配对照者的骨折比较:一项大型队列研究

Fractures in Patients With Acute Calcium Pyrophosphate Crystal Arthritis Versus Matched Comparators in a Large Cohort Study.
PubMed 文献 · Arthritis Rheumatol · 2024-02-08

本研究基于1991至2023年单一大型学术医疗系统的电子健康记录开展纵向队列研究,比较急性焦磷酸钙晶体关节炎患者与匹配对照者的骨折风险。共纳入1148例急性焦磷酸钙晶体关节炎患者与3730例对照者,平均年龄73岁。急性焦磷酸钙晶体关节炎队列骨折发生率为每1000人年11.7例,对照组为每1000人年5.5例,多变量调整后风险比1.8(95%CI 1.3-2.3)。

要点

  • 急性焦磷酸钙晶体关节炎患者骨折发生率为每1000人年11.7例,匹配对照者为每1000人年5.5例
  • 多变量调整后骨折风险比1.8(95%CI 1.3-2.3),敏感性分析结果相似
  • 急性焦磷酸钙晶体关节炎队列中糖皮质激素和骨质疏松治疗的使用比对照组更频繁

核心结论

  • 在首个已发表的关于骨折与焦磷酸钙沉积病的研究中,急性焦磷酸钙晶体关节炎患者的骨折风险接近翻倍。

研究设计与样本

  • 纵向队列研究,使用单一大型学术医疗系统1991至2023年的电子健康记录数据。
  • 急性焦磷酸钙晶体关节炎患者与对照者在索引日期(首次记录「假性痛风」或滑液焦磷酸钙晶体或匹配就诊)及首次就诊于该系统时进行匹配。
  • 共识别1148例急性焦磷酸钙晶体关节炎患者,匹配3730例对照者,平均年龄73岁。
  • 主要结局为肱骨、腕部、髋部或骨盆的首次骨折;排除了索引日期前已有骨折的患者。
  • 协变量包括人口学特征、体重指数、吸烟、合并症、医疗使用、糖皮质激素和骨质疏松治疗。

主要发现

  • 急性焦磷酸钙晶体关节炎队列中糖皮质激素和骨质疏松治疗的使用比对照组更频繁。
  • 骨折发生率在急性焦磷酸钙晶体关节炎队列为每1000人年11.7例,对照组为每1000人年5.5例。
  • 多变量调整后,急性焦磷酸钙晶体关节炎队列的骨折相对风险为对照组的2倍(风险比1.8,95%CI 1.3-2.3)。
  • 敏感性分析(排除使用糖皮质激素者、排除使用骨质疏松治疗者、排除类风湿关节炎患者,以及额外调整慢性肾脏病)结果相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Calcium pyrophosphate deposition (CPPD) disease was associated with osteopenia in two cross-sectional studies. We compared fracture risks in patients with acute calcium pyrophosphate (CPP) crystal arthritis versus matched comparators. METHODS: We performed a longitudinal cohort study using electronic health record data from a single large academic health system, with data from 1991 to 2023. Patients with one or more episodes of acute CPP crystal arthritis were matched to comparators on the index date (first documentation of "pseudogout" or synovial fluid CPP crystals or matched encounter) and first encounter in the health system. The primary outcome was first fracture at the humerus, wrist, hip, or pelvis. We excluded patients with fracture before the index date. Covariates included demographics, body mass index, smoking, comorbidities, health care use, glucocorticoids, and osteoporosis treatments. We estimated incidence rates and adjusted hazard ratios for fracture. Sensitivity analyses excluded patients prescribed glucocorticoids, patients prescribed osteoporosis treatments, or patients with rheumatoid arthritis and additionally adjusted for chronic kidney disease. RESULTS: We identified 1,148 patients with acute CPP crystal arthritis matched to 3,730 comparators, with a mean age of 73 years. Glucocorticoids and osteoporosis treatments were more frequent in the acute CPP crystal arthritis cohort. Fracture incidence rates were twice as high in the acute CPP crystal arthritis cohort (11.7 per 1,000 person-years) versus comparators (5.5 per 1,000 person-years). After multivariable adjustment, fracture relative risk was twice as high in the acute CPP crystal arthritis cohort (hazard ratio 1.8 [95% confidence interval 1.3-2.3]); results were similar in sensitivity analyses. CONCLUSION: In this first published study of fractures and CPPD, fracture risk was nearly doubled in patients with acute CPP crystal arthritis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Tedeschi SK, Hayashi K, Rosenthal A, et al. Fractures in Patients With Acute Calcium Pyrophosphate Crystal Arthritis Versus Matched Comparators in a Large Cohort Study. Arthritis Rheumatol. 2024. PMID: 38221723. doi:10.1002/art.42798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。